XOMA Royalty (XOMA) Equity Ratio (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Equity Ratio came in at 0.34 in Q1 2026, up 12.49% year-on-year from 0.3 in Q1 2025, and up 10.99% quarter-over-quarter from 0.31 in Q4 2025.

XOMA Royalty (XOMA) Equity Ratio (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Equity Ratio across 17 years of filings, most recently posting 0.34 for Q1 2026.

  • Equity Ratio for Q1 2026 came in at 0.34, up 12.49% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.34 (up 12.49% YoY), and the FY2025 annual result was 0.31, up 10.03% from the prior year.
  • Equity Ratio came in at 0.34 for Q1 2026 at XOMA Royalty, up from 0.31 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.89 in Q3 2022 to a low of 0.28 in Q4 2024.
  • The 5-year median for Equity Ratio is 0.33 (2025), against an average of 0.54.
  • Across the five-year window, Equity Ratio climbed 28.98% in 2022 and tumbled 66.85% in 2024, its largest moves.
  • XOMA Royalty's Equity Ratio stood at 0.88 in 2022, then plunged by 66.81% to 0.29 in 2023, then fell by 4.59% to 0.28 in 2024, then advanced by 10.03% to 0.31 in 2025, then gained by 10.99% to 0.34 in 2026.
  • The last three Equity Ratio figures came in at 0.34 (Q1 2026), 0.31 (Q4 2025), and 0.33 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 191.07
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 0.98
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 0.04
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.58
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 0.42
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 0.73
9 Abivax 95.45 Bn 95.45 Bn - 0.79
10 XOMA Royalty 5.52 Mn -60.56 Mn - 0.34

Historic Data

Download Data
DateValue
Mar 31, 2026 0.34
Dec 31, 2025 0.31
Sep 30, 2025 0.33
Jun 30, 2025 0.32
Mar 31, 2025 0.30
Dec 31, 2024 0.28
Sep 30, 2024 0.29
Jun 30, 2024 0.33
Mar 31, 2024 0.28
Dec 31, 2023 0.29
Sep 30, 2023 0.85
Jun 30, 2023 0.88
Mar 31, 2023 0.86
Dec 31, 2022 0.88
Sep 30, 2022 0.89
Jun 30, 2022 0.88
Mar 31, 2022 0.88
Dec 31, 2021 0.85
Sep 30, 2021 0.86
Jun 30, 2021 0.86